Status:

COMPLETED

Interest of Catalepsy in the Hypnotic Trance

Lead Sponsor:

CMC Ambroise Paré

Conditions:

Hypnosis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Catalepsy seems to facilitate hypnotic induction and deepen hypnotic trance, although no work confirms the usefulness of this technique which is in common use in hypnosis. Furthermore, it has been sho...

Detailed Description

After randomization, subjects will either benefit from the normal hypnotic trance, or from the hypnotic trance associated with catalepsy of the hand. T0 = installation in a sitting position and colle...

Eligibility Criteria

Inclusion

  • Healthy Volunteers
  • Consent for participation
  • Affiliation to the social security system

Exclusion

  • Arrhythmia (atrial fibrillation, pacemaker, defibrillator)
  • Autonomic nervous system disorder (paraplegia, epilepsy, etc.)
  • Pregnant or breastfeeding woman
  • Patients under protection of the adults (guardianship, curators or safeguard of justice)
  • Communication difficulties

Key Trial Info

Start Date :

May 26 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 28 2022

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05306262

Start Date

May 26 2022

End Date

May 28 2022

Last Update

June 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Emergences

Rennes, France